SIRT1 activator ameliorates the renal tubular injury induced by hyperglycemia in vivo and in vitro via inhibiting apoptosis | |
Wang, Xue-ling; Wu, Li-yan; Zhao, Long; Sun, Li-na; Liu, Hai-ying; Liu, Gang; Guan, Guang-ju | |
刊名 | BIOMEDICINE & PHARMACOTHERAPY
![]() |
2016 | |
卷号 | 83页码:41-50 |
关键词 | Resveratrol Diabetic nephropathy HK-2 cells SIRT1 p53 Apoptosis |
DOI | 10.1016/j.biopha.2016.06.009 |
URL标识 | 查看原文 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4695001 |
专题 | 山东大学 |
作者单位 | Shandong Univ, Hosp 2, Nephrol Res Inst, Jinan, Shandong, Peoples R |
推荐引用方式 GB/T 7714 | Wang, Xue-ling,Wu, Li-yan,Zhao, Long,et al. SIRT1 activator ameliorates the renal tubular injury induced by hyperglycemia in vivo and in vitro via inhibiting apoptosis[J]. BIOMEDICINE & PHARMACOTHERAPY,2016,83:41-50. |
APA | Wang, Xue-ling.,Wu, Li-yan.,Zhao, Long.,Sun, Li-na.,Liu, Hai-ying.,...&Guan, Guang-ju.(2016).SIRT1 activator ameliorates the renal tubular injury induced by hyperglycemia in vivo and in vitro via inhibiting apoptosis.BIOMEDICINE & PHARMACOTHERAPY,83,41-50. |
MLA | Wang, Xue-ling,et al."SIRT1 activator ameliorates the renal tubular injury induced by hyperglycemia in vivo and in vitro via inhibiting apoptosis".BIOMEDICINE & PHARMACOTHERAPY 83(2016):41-50. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论